title: Targeting of high-capacity adenoviral vectors.
abstract: High-capacity adenoviral (HC-Ad) vectors contain only the noncoding termini of the viral genome, can deliver large DNA fragments of up to 36 kb into target cells, and feature reduced toxicity and prolonged transgene expression in vivo. To enhance the potential of HC-Ad vectors to transduce specific cell types, we constructed a versatile infectious new helper virus plasmid that can be used readily to introduce peptide ligands into the HI loop of the fiber knob domain of Ad5-based HC-Ad vectors. Helper viruses with a 6x-His epitope or Arg-Gly-Asp (RGD) peptide insertion retained the full infectivity of the wild-type helper virus. The RGD-modified helper virus was used for production of a capsid-modified HC-Ad vector expressing beta-galactosidase. The RGD HC-Ad vector transduced the ovarian carcinoma cell lines SK-OV-3 and OVCAR-3 with 4- to 20-fold higher efficiency, compared to unmodified vectors. Transduction of both primary vascular smooth muscle cells as well as primary human endothelial cells was increased up to 15-fold with the RGD-modified vector. Competition experiments with recombinant knob protein and different RGD peptides indicated that the RGD-mediated transduction was Coxsackie and Adenovirus receptor (CAR)-independent and involved integrin alpha(v)beta(5). The use of fiber-modified helper viruses in the last amplification step of HC-Ad vector production allows for convenient and efficient targeting of these vectors towards different cell types. Targeting strategies will increase the spectrum of applications for HC-Ad vectors and will further add to their safety.
authors.affiliation: Center for Molecular Medicine (ZMMK) and Institute for Genetics, University of Cologne, D-50931 Cologne, Germany.
authors.forename: V
authors.initials: V
authors.lastname: Biermann
authors.forename: C
authors.initials: C
authors.lastname: Volpers
authors.forename: S
authors.initials: S
authors.lastname: Hussmann
authors.forename: A
authors.initials: A
authors.lastname: Stock
authors.forename: H
authors.initials: H
authors.lastname: Kewes
authors.forename: G
authors.initials: G
authors.lastname: Schiedner
authors.forename: A
authors.initials: A
authors.lastname: Herrmann
authors.forename: S
authors.initials: S
authors.lastname: Kochanek
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D001667:Binding, Competitive; D015153:Blotting, Western; D002478:Cells, Cultured; D003001:Cloning, Molecular; D062727:Coxsackie and Adenovirus Receptor-Like Membrane Protein; D004727:Endothelium / Q000166:cytology; D000939:Epitopes; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D016679:Genome, Viral; D006378:Helper Viruses / Q000235:genetics; D006801:Humans; D008024:Ligands; D008957:Models, Genetic; D009130:Muscle, Smooth / Q000166:cytology; D009842:Oligopeptides / Q000235:genetics; D010455:Peptides / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D010957:Plasmids / Q000378:metabolism; D017434:Protein Structure, Tertiary; D015800:Protozoan Proteins; D011991:Receptors, Virus / Q000378:metabolism; D014161:Transduction, Genetic; D014407:Tumor Cells, Cultured; D001616:beta-Galactosidase / Q000378:metabolism
chemical_list: C568771:CLMP protein, human; D062727:Coxsackie and Adenovirus Receptor-Like Membrane Protein; D000939:Epitopes; D008024:Ligands; D009842:Oligopeptides; D010455:Peptides; D015800:Protozoan Proteins; D011991:Receptors, Virus; C042968:knob protein, Plasmodium falciparum; C047981:arginyl-glycyl-aspartic acid; D001616:beta-Galactosidase